L
L

LaboratoryCorporation


أخبار

U.S. Fedex, Workiva, European Wax Center

U.S. RESEARCH ROUNDUP- Fedex, Workiva, European Wax Center Sept 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including European Wax Center, Fedex and Workiva on Thursday. HIGHLIGHTS * European Wax Center Inc EWCZ.O : Piper Sandler raises to overweight from neutral * Fedex Corp FDX.N : Jefferies raises target price to $265 from $245 * Frontier Group Holdings Inc ULCC.O : Citigroup cuts to neutral from buy * Truist Financi
A
A
C
C
E
G
E
S
A
E
J
L

U.S. CNH Industrial, Deere & Co, Hancock Whitney

U.S. RESEARCH ROUNDUP-CNH Industrial, Deere & Co, Hancock Whitney Sept 19 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CNH Industrial, Deere & Co and Hancock Whitney, on Tuesday. HIGHLIGHTS * CNH Industrial CNHI.N : Evercore ISI cuts to in-line from outperform * Deere & Co DE.N : Evercore ISI cuts to in-line from outperform * Hancock Whitney Corp HWC.O : Piper Sandler raises to overweight from neutral * Kinnate Bi
N
S
S
S
C
D
A
L
R

Lab operators show base business strength going into H2 2023- Baird

BUZZ-Lab operators show base business strength going into H2 2023- Baird ** Brokerage Baird says lab operators like Laboratory Corp of America Holdings LH.N and Quest Diagnostics DGX.N have "largely resolved" investor concerns that troubled H1 2023 ** Fortrea spin completion and alternate lab monkey sourcing leaves LH to focus on core diagnostics b
L

U.S. Associated Banc-Corp, Celanese Corporation, Hess

U.S. RESEARCH ROUNDUP-Associated Banc-Corp, Celanese Corporation, Hess Sept 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Associated Banc-Corp, Celanese Corporation and Hess on Wednesday. HIGHLIGHTS * Associated Banc-Corp ASB.N : Baird raises to outperform * Celanese Corporation CE.N : Keybanc raises to overweight from sector weight * Constellation Brands Inc STZ.N : TD Cowen raises to outperform from market perf
A
A
B
C
D
E
G
S
E
A
C
E
I
L

Jana Partners Cuts Share Stake In Laboratory Corporation Of America

BRIEF-Jana Partners Cuts Share Stake In Laboratory Corporation Of America Aug 14 (Reuters) - Jana Partners LLC: JANA PARTNERS LLC CUTS SHARE STAKE IN LABORATORY CORPORATION OF AMERICA BY 39.5% TO 401,935 SHARES - SEC FILING JANA PARTNERS LLC - CHANGE IN HOLDINGS ARE AS OF JUNE 30, 2023, AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF MARCH 31, 2
L

Labcorp cuts 2023 profit forecast after clinical development unit spin-off

UPDATE 1-Labcorp cuts 2023 profit forecast after clinical development unit spin-off Adds CEO comment from the conference call in paragraph 4 By Mariam Sunny July 27 (Reuters) - Laboratory Corp of America Holdings LH.N cut its annual profit forecast on Thursday following the spin off of its clinical development business, Fortrea FTRE.O . The lab operator has been struggling with a shortage of lab monkeys due to curbs on animal imports after a Cambodian supplier was charged in connection with ille
L

Laboratory Corporation of America Holdings reports results for the quarter ended in June - Earnings Summary

Laboratory Corporation of America Holdings reports results for the quarter ended in June - Earnings Summary Laboratory Corporation of America Holdings LH.N reported quarterly adjusted earnings of $3.80​​ per share for the quarter ended in June. The mean expectation of fifteen analysts for the quarter was for earnings of $3.53 per share. Revenue fell 17.9% to $3.03 billion from a year ago; analysts expected $3.15 billion.
L

Labcorp cuts 2023 profit forecast on drug development spin-off

CORRECTED-Labcorp cuts 2023 profit forecast on drug development spin-off Corrects headline and paragraph 1 to say profit forecast cut due to spin off of company's clinical development unit; removes reference to lab monkey shortage in paragraph 2 July 27 (Reuters) - Laboratory Corp of America Holdings LH.N cut its annual profit forecast on Thursday due to the spin off of the company's drug development business.
L

Labcorp Q2 Adjusted EPS USD 3.42 Vs. IBES Estimate USD 3.53

Jul 27 (Reuters) - Labcorp Q2 adjusted EBIT USD 448.3 million vs. IBES estimate USD 463 million. Q2 EPS USD 1.74 Q2 revenue USD 3,030 million vs. IBES estimate USD 3,154 million Q2 EBIT USD 266.3 million
L

REUTERS NEWS SCHEDULE AT 6 a.m GMT/2 p.m. SGT

REUTERS NEWS SCHEDULE AT 6 a.m GMT/2 p.m. SGT Here are the top stories and upcoming coverage plans for Reuters text service as of 6 a.m GMT/2 p.m. SGT. For a full schedule of news and events, go to our editorial calendar on Reuters Connect . TOP STORIES GLOBAL NORTHKOREA-ANNIVERSARY/ North Korea's Kim shows off banned missiles to Russian minister Russia's defence minister accompanied North Korean leader Kim Jong Un to a defence exhibition that featured the North's banned ballistic missiles as th
B
M
N
V
A
U
H
R
L
L

What to Watch in the Day Ahead - Thursday, July 27

What to Watch in the Day Ahead - Thursday, July 27 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT On the U.S. economic front, the Commerce Department is set to report that the gross domestic product increased at a 1.8% annualized rate last quarter, in its advance estimate of second-quarter GDP
D
I
M
V
T
H
R
L

Quest Diagnostics beats profit estimates as routine testing picks up

Quest Diagnostics beats profit estimates as routine testing picks up July 26 (Reuters) - Laboratory operator Quest Diagnostics Inc DGX.N beat estimates for quarterly profit on Wednesday, as people returned for regular checkups and tests that were delayed during a large part of the COVID-19 pandemic. Non-COVID testing at companies such as Quest and rival Labcorp LH.N was hit as people delayed routine health check-ups following pandemic-led lockdowns, but that demand has now started to normalize w
A
L

U.S. STOCKS Archer-Daniels-Midland, Nucor, Copper miners

BUZZ-U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stocks gained on Tuesday amid choppy trading that could see the Dow log a 12-day rally ahead of quarterly earnings reports from megacap technology companies Alphabet GOOGL.O and Microsoft MSFT.O, and a rate hike by the Federal Reserve.
B
C
C
G
J
M
N
A
R
T
U
U
U
D
S
S
T
A
D
L
L
P

U.S. STOCKS Hubbell, Spire Global, FibroGen

BUZZ-U.S. STOCKS ON THE MOVE-Hubbell, Spire Global, FibroGen Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The tech-heavy Nasdaq and the S&P 500 edged up amid choppy trading on Tuesday as investors geared up for quarterly earnings reports from megacap technology companies Alphabet and Microsoft, and a rate hike by the Federal Reserve.
B
C
C
G
J
M
M
N
A
T
U
U
U
D
S
S
T
A
D
L
L
P

Laboratory Corporation of America Holdings expected to post earnings of $3.48 a share - Earnings Preview

Laboratory Corporation of America Holdings expected to post earnings of $3.48 a share - Earnings Preview Laboratory Corporation of America Holdings LH.N , LH is expected to show a fall in quarterly revenue when it reports results on July 27. The Burlington North Carolina-based company is expected to report a 18.5% decrease in revenue to $3.014 billion from $3.7 billion a year ago, according to the mean estimate from 4 analysts, based on Refinitiv data.
L

U.S. STOCKS Verizon Communications, Danaher, General Electric

BUZZ-U.S. STOCKS ON THE MOVE-Verizon Communications, Danaher, General Electric Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq was set for a slightly higher open on Tuesday after multiple companies forecast upbeat annual profits, while investors also awaited quarterly earnings reports from megacap technology companies.
A
B
C
M
V
U
D
S
S
T
A
D
L

U.S. STOCKS China ADRs, Enzo Biochem, Humanigen

BUZZ-U.S. STOCKS ON THE MOVE-China ADRs, Enzo Biochem, Humanigen Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Dow futures were subdued on Tuesday, lagging Wall Street peers, following an 11-day rally by the blue-chip index, while investors awaited quarterly earnings from megacap technology companies.
A
B
C
M
V
U
D
S
A
L

Enzo Biochem after completing sale of labs to Labcorp

BUZZ-Enzo Biochem after completing sale of labs to Labcorp ** Enzo Biochem Inc's shares ENZ.N rise 19.8% to $1.6 premarket ** Co said late on Monday it has closed a transaction to sell all of its labs located in New York metropolitan region to Laboratory Corporation of America LH.N under a March agreement ** Under the deal, ENZ to receive $113.3 mi
L

Enzo Biochem Completes Sale Of Clinical Laboratory To Labcorp

BRIEF-Enzo Biochem Completes Sale Of Clinical Laboratory To Labcorp July 24 (Reuters) - Enzo Biochem Inc ENZ.N : ENZO BIOCHEM COMPLETES SALE OF CLINICAL LABORATORY TO LABCORP Source text for Eikon: ID:nGNX4GStN0 Further company coverage: ENZ.N
L

Dow leads Wall St gains with 11-session advance

LIVE MARKETS-Dow leads Wall St gains with 11-session advance Wall St's three major indexes gain with Dow out front, up 0.5% Energy leads sector gains, utilities weakest Dollar up 0.3%; gold down 0.3%; oil up >2%; bitcoin falls >2% U.S. Treasury 10-year yield rises to ~3.87% Welcome to the home for real-time coverage of markets brought to you by Reuters reporters.
A
A
C
F
G
H
J
M
N
U
U
U
S
T
C
L



الشروط

الأصول الشائعة

إخلاء المسؤولية: تتيح كيانات XM Group خدمة تنفيذية فقط والدخول إلى منصة تداولنا عبر الإنترنت، مما يسمح للشخص بمشاهدة و/أو استخدام المحتوى المتاح على موقع الويب أو عن طريقه، وهذا المحتوى لا يراد به التغيير أو التوسع عن ذلك. يخضع هذا الدخول والاستخدام دائماً لما يلي: (1) الشروط والأحكام؛ (2) تحذيرات المخاطر؛ (3) إخلاء المسؤولية الكامل. لذلك يُقدم هذا المحتوى على أنه ليس أكثر من معلومات عامة. تحديداً، يرجى الانتباه إلى أن المحتوى المتاح على منصة تداولنا عبر الإنترنت ليس طلباً أو عرضاً لدخول أي معاملات في الأسواق المالية. التداول في أي سوق مالي به مخاطرة عالية برأس مالك.

جميع المواد المنشورة على منصة تداولنا مخصصة للأغراض التعليمية/المعلوماتية فقط ولا تحتوي - ولا ينبغي اعتبار أنها تحتوي - على نصائح أو توصيات مالية أو ضريبية أو تجارية، أو سجلاً لأسعار تداولنا، أو عرضاً أو طلباً لأي معاملة في أي صكوك مالية أو عروض ترويجية مالية لا داعي لها.

أي محتوى تابع للغير بالإضافة إلى المحتوى الذي أعدته XM، مثل الآراء، والأخبار، والأبحاث، والتحليلات والأسعار وغيرها من المعلومات أو روابط مواقع تابعة للغير وواردة في هذا الموقع تُقدم لك "كما هي"، كتعليق عام على السوق ولا تعتبر نصيحة استثمارية. يجب ألا يُفسر أي محتوى على أنه بحث استثماري، وأن تلاحظ وتقبل أن المحتوى غير مُعدٍ وفقاً للمتطلبات القانونية المصممة لتعزيز استقلالية البحث الاستثماري، وبالتالي، فهو بمثابة تواصل تسويقي بموجب القوانين واللوائح ذات الصلة. فضلاً تأكد من أنك قد قرأت وفهمت الإخطار بالبحوث الاستثمارية غير المستقلة والتحذير من مخاطر المعلومات السابقة، والذي يمكنك الاطلاع عليه هنا.

نحن نستخدم ملفات الكوكيز لنمنحك أفضل تجربة على موقعنا. يمكنك قراءة المزيد أو تغيير إعدادات الكوكيز.

تحذير المخاطر: رأس مالك في خطر. المنتجات التي تستخدم الرافعة قد لا تكون مناسبة للجميع. يرجى الاطلاع على تنبيه المخاطر.